Publications
Detailed Information
ROS-mediated SIRT2 activation by genistein induces pro-survival autophagy in cisplatin resistant ovarian cancer cells
Cited 0 time in
Web of Science
Cited 0 time in Scopus
- Authors
- Advisor
- 송용상
- Major
- 의과대학 협동과정 종양생물학전공
- Issue Date
- 2015-08
- Publisher
- 서울대학교 대학원
- Keywords
- ROS ; Autophagy ; SIRT2 ; Chemoresistance
- Description
- 학위논문 (석사)-- 서울대학교 대학원 : 협동과정 종양생물학전공, 2015. 8. 송용상.
- Abstract
- The most serious problem of ovarian cancer is chemoresistance. Autophagy is one of the phenotype contributing to chemoresistance and also has the bidirectional effect during chemotherapy. In this study, we demonstrated that ROS-induced autophagy by genistein has opposing functions regarding chemoresistance in ovarian cancer cell line A2780/CP (cisplatin resistant) and A2780/S (cisplatin sensitive). Genistein induced cell death through ROS generation. Interestingly, with ROS scavenging, the cell death rate was increased in A2780/CP in contrast to decrease in A2780/S. Genistein increased autophagy in both cell lines and the addition of autophagy inhibitor, 3MA, showed the same pattern of cell death rate as that of ROS scavenging. It means that the function of autophagy by genistein was different, pro-survival in A2780/CP while pro-death in A2780/S. SIRT2 promotes autophagy as a defense against the oxidative stress. AGK2, SIRT2 inhibitor, similarly inhibited cell viabilities in both cell lines. Moreover, AGK2 inhibited pro-survival autophagy in A2780/CP and overcame the cisplatin resistance with genistein. Taken together, understanding the autophagy could help to develop the therapeutic design to overcome the chemoresistance in ovarian cancer.
- Language
- English
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.